182 related articles for article (PubMed ID: 31341419)
1. Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis.
Kolodziej AR; Abo-Aly M; Elsawalhy E; Campbell C; Ziada KM; Abdel-Latif A
Mediators Inflamm; 2019; 2019():2872607. PubMed ID: 31341419
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
Liu SC; Yi TC; Weng HY; Zhang L; Li YX; Mohetaboer M; Zhang Y; Jiang J; Li JP; Huo Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):284-291. PubMed ID: 29747324
[No Abstract] [Full Text] [Related]
4. Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy.
Karadag B; Vatan B; Hacioglu Y; Duman D; Baskurt M; Keles I; Ongen Z; Vural VA
Heart Vessels; 2009 Jul; 24(4):247-53. PubMed ID: 19626395
[TBL] [Abstract][Full Text] [Related]
5. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
Morrow DA; Sabatine MS; Brennan ML; de Lemos JA; Murphy SA; Ruff CT; Rifai N; Cannon CP; Hazen SL
Eur Heart J; 2008 May; 29(9):1096-102. PubMed ID: 18339606
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic value of myeloperoxidase on acute coronary syndrome: a meta-analysis.
Chen Y; Zhang F; Dong L; Shu X
Arch Med Res; 2011 Jul; 42(5):368-74. PubMed ID: 21803086
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
[TBL] [Abstract][Full Text] [Related]
9. Serial analyses of C-reactive protein and myeloperoxidase in acute coronary syndrome.
Borges FK; Borges FK; Stella SF; Souza JF; Wendland AE; Werres Junior LC; Ribeiro JP; Polanczyk CA
Clin Cardiol; 2009 Nov; 32(11):E58-62. PubMed ID: 19816870
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z
J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
[TBL] [Abstract][Full Text] [Related]
13. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis.
Wang Y; Zhen C; Wang R; Wang G
Am J Emerg Med; 2019 Jul; 37(7):1346-1352. PubMed ID: 31029521
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Multiple Cardiac Biomarkers in Newly Diagnosed Acute Coronary Syndrome Patients.
Rahman MM; Alam MM; Jahan NA; Shila JS; Arslam MI
Mymensingh Med J; 2016 Apr; 25(2):326-33. PubMed ID: 27277367
[TBL] [Abstract][Full Text] [Related]
15. [The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].
Kai F; Lifeng L; Haijing S; Xianhua L; Hu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):970-4. PubMed ID: 27318339
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kacprzak M; Zielinska M
Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
[TBL] [Abstract][Full Text] [Related]
17. The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department.
Searle J; Shih J; Muller R; Vollert JO; Müller C; Danne O; Datwyler S; Möckel M
Eur Heart J Acute Cardiovasc Care; 2013 Sep; 2(3):203-10. PubMed ID: 24222831
[TBL] [Abstract][Full Text] [Related]
18. Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction.
Kaya MG; Yalcin R; Okyay K; Poyraz F; Bayraktar N; Pasaoglu H; Boyaci B; Cengel A
Tex Heart Inst J; 2012; 39(4):500-6. PubMed ID: 22949765
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up.
Mignano A; Pitruzzella V; Arnone G; Arnone MT; Rotolo A; Assennato P; Novo G; Corrado E; Novo S
J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):27-32. PubMed ID: 23867910
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction.
Khan SQ; Kelly D; Quinn P; Davies JE; Ng LL
Heart; 2007 Jul; 93(7):826-31. PubMed ID: 17194712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
